{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-027621","form_type":"8-K/A","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.382037+00:00","generated_at":"2026-05-31T08:06:03.781039+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Reviva Pharmaceuticals raises $3.8M net in public offering of common stock and warrants","bullets":["Net proceeds from offering updated to $3.8M; closed Aug 22, 2024.","Sold 3,276,262 shares at $1.05/share along with warrants to purchase up to 4,761,905 shares at $0.7964.","Also issued pre-funded warrants for 1,485,643 shares and underwriter warrants for 238,095 shares at $1.3125.","Existing warrants from 2021 and 2023 amended: exercise price lowered to $0.7964, expiration extended to 5 years.","Titan Partners Group underwriter; 8.0% commission and expense reimbursement."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-027621","json":"https://secwatch.observer/filing/0001437749-24-027621.json","markdown":"https://secwatch.observer/filing/0001437749-24-027621.md","text":"https://secwatch.observer/filing/0001437749-24-027621.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/0001437749-24-027621-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924027621/rvph20240822_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:06:03.781039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}